Sun Pharma Corporate Overview

Creating a Global Company DUSA a SUN PHARMA company Began with 5 products Acquired Dusa MERCK Agreement with Merck for in- licensing Tildrakizumab InSite Vision Solutions for Sight +Biosintez a SUN PHARMA company Acquired POLA PHARMA Acquired InSite Vision ophthalmic portfolio Biosintez in Russia Acquired Pola Pharma in Japan SUN PHARMA Year- 1983 1994 2010 2012 2013 2014 2015 2016 2018 2019 2020 IPO Rs. 550 Mn raised TARO Acquired Taro Sun Pharma Today URL PHARMA Acquired URL Pharma RANBAXY LABORATORIES LIMITED Acquired Ranbaxy Entry into Japan -Acquired 14 brands from Novartis • Acquired Global rights for Cequa & Odomzo Launch of Specialty products Ilumya Cequa Odomzo • Absorica LD Yonsa Xelpros Sprinkle products 37,000+ Global Employee Base Invested over Rs. 193 Bn in R&D till date (Since 1994) © Sun Pharmaceutical Industries Limited. All Rights Reserved. BSE SENSEX NIFTY тубб Stock of the nation Part of NSE Nifty & BSE Sensex in India 44 Manufacturing facilities in 6 Continents 67% of sales from international markets 14

View entire presentation